Nabumetone
Product Images NDC 0115-1657

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 0115-1657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nabumetone Tablets Usp 1)

FDA Label Image

Parent Compound Chemical Structure (Nabumetone Tablets Usp 2)

FDA Label Image

Figure (Nabumetone Tablets Usp 3)

FDA Label Image

500mg-100ct (Nabumetone Tablets Usp 4)

500mg-100ct (Nabumetone Tablets Usp 4)
Nabumetone is a medication available in tablet form in the US. The usual dosage information can be found in the package insert. The tablets contain 500mg of the active ingredient, USP nabumetone. This medication is only available with a prescription and should be kept out of reach of children. The distributor is Impax Gere located in Hayward, CA, and the product is manufactured in India. The product has a GTIN of 00301151657014 and an NDC of 0115-1657-01. The description also includes a patent number and a revision date.*
FDA Label Image

750mg-100ct (Nabumetone Tablets Usp 5)

750mg-100ct (Nabumetone Tablets Usp 5)
This is a prescription drug, Nabumetone, in the form of Tablets, USP. Each tablet contains 750 mg of the drug. The provided information also directs the pharmacist to dispense the accompanying medication guide to each patient. Information related to the patient or the usage of the drug is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.